𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinico-pathology and prognosis of endometrial cancer in patients previously treated for breast cancer, with or without tamoxifen: A comparative study in 363 patients

✍ Scribed by Ngô, C.; Brugier, C.; Plancher, C.; de la Rochefordière, A.; Alran, S.; Féron, J.G.; Malhaire, C.; Scholl, S.; Sastre, X.; Rouzier, R.; Fourchotte, V.

Book ID
124112855
Publisher
Elsevier Science
Year
2014
Tongue
English
Weight
1011 KB
Volume
40
Category
Article
ISSN
0748-7983

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Outcomes in patients with primary breast
Outcomes in patients with primary breast cancer and a subsequent diagnosis of endometrial cancer : Comparison of cohorts treated with and without tamoxifen
✍ Mandana Saadat; Pauline T. Truong; Hosam A. Kader; Caroline H. Speers; Eric Bert 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

## Abstract ## BACKGROUND. The study compared tumor characteristics and survival in women with breast cancer who subsequently developed endometrial cancer with or without a history of tamoxifen use. ## METHODS. The British Columbia Cancer Agency registry identified 163 women diagnosed with breas

Genetic polymorphisms of CYP2D6*10 and C
Genetic polymorphisms of CYP2D6*10 and CYP2C19*2, *3 are not associated with prognosis, endometrial thickness, or bone mineral density in Japanese breast cancer patients treated with adjuvant tamoxifen
✍ Matthew Goetz; Vera Suman 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB 👁 1 views

The study by Okishiro et al 1 concludes that the cytochrome P450 (CYP) genotype CYP2D6\*10/\*10 is unlikely to have a clinically significant impact on prognosis in women with breast cancer who receive adjuvant tamoxifen. However, several aspects of the study by Okishiro et al call their conclusions